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Background: Ischemic stroke and glioblastoma multiforme have similar features on anatomic magnetic resonance
imaging (MRI) and thus may require a surgical biopsy for a definitive diagnosis.
Case presentation: A 55-year-old male complained of dysphasia for 4 weeks and continuous deterioration for 5
days. Cerebral infarction was considered based on MRI, which showed hyperintensity at the border zone of the left
hemisphere, and computed tomography angiography (CTA) showed left carotid artery severe stenosis. The patient
underwent placement of a left carotid artery stent, and his symptoms recurred 2 months after carotid artery stent
(CAS). MRI showed multiple ring-enhanced lesions in the left temporal, parietal, and occipital lobes accompanied by
massive brain edema. The final pathologic diagnosis was glioblastoma multiforme.
Conclusion: Although there is no evidence that stent therapy for carotid artery stenosis will worsen an ipsilateral
glioblastoma, we should be careful to perform surgeries involving carotid artery stents when the patient has a
glioblastoma.
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Ischemic stroke is a leading health problem in China,
and is the most common disease in elderly people [1].
Glioblastoma multiforme (GBM) is a World Health
Organization (WHO) grade IV tumor with a dismal
prognosis; <10 % of patients are alive after 2 years [2].
Co-existing ischemic stroke with carotid artery stenosis
and GBM is rare. The patient described herein presented
three times with ischemic strokes complicated by left ca-
rotid artery severe stenosis. Magnetic resonance imaging
(MRI) showed an infarct pattern consistent with a water-
shed infarction. Two months after left carotid artery
stent (CAS), multiple lesions were noted in the left cere-
bral hemisphere with massive edema, and a GBM was
diagnosed post-operatively. There are some issues
worthy of discussion about the clinical diagnosis, ther-
apy, and blood flow after CAS-induced deterioration.* Correspondence: wangqidongzy@163.com
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A 55-year-old male patient complained of dysphasia for
4 weeks and continuous deterioration for 5 days. The
patient had a history of ischemic stroke (Fig. 1a, b),
which manifested as right limb numbness and amaurosis
1 year ago. He had a history of hypertension for 10 years,
a myocardial infarction 3 years ago, and cigarette smoking
for 40 years, but no history of diabetes, hyperlipidemia,
and alcohol consumption. The patient exhibited a disorder
of linguistic expression and long-term memory impairment
without a limb motor disorder. Cranial MRI confirmed an
ischemic stroke at a local hospital (Fig. 1c, d). The symp-
toms were relieved after medical treatment. The dysphasia
relapsed 5 days before admission. Cranial computed tom-
ography (CT) showed a hypodense lesion in the left
temporal and occipital lobes (Fig. 1e). Cerebral infarc-
tion was considered based on serial cranial MRI,
which showed hyperintensity at the internal border
zone and the border zone between the left temporal
and occipital lobes, and Doppler ultrasound revealed
severe left carotid artery stenosis. The patient was
transferred to our stroke center for further treatment.istributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Patient images before carotid artery stenting. a (T2WI [2013-5-5]) and b (T2WI [2013-10-14]):T2-weighted image shows internal border
zone cerebral infarction. c, d (2014-12-2): T2 flair image and T2-weighted image showed hyperintensity in the left temporal and occipital lobes.
e (2014-12-26): CT image showed low density in the left internal border zone and temporal and occipital lobes. f CT perfusion image showed
mild cerebral ischemia of left cerebral hemisphere. g CT angiography (2015-01-03) showed severe left carotid artery stenosis. h, i DSA showed severe
left carotid artery stenosis with stenting therapy. (j): 3-month follow-up CT angiography of left carotid artery after carotid artery stenting
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A neurologic examination showed mild dysphasia, normal
cranial nerves, normal limb motor function, and negative
Babinski signs bilaterally. CT perfusion imaging showed
mild ischemic in the territory of the left middle cerebral
artery (Fig. 1f). Cervical computed tomography angiog-
raphy (CTA) confirmed the first segment of the carotid
artery with severe stenosis (Fig. 1g). An electrocardiogram
revealed an abnormal Q-wave involving the inferior wall,
which was consistent with an inferior myocardial infarc-
tion. Homocysteine (35.3 μmol/L) and the following
laboratory investigations were normal: triglycerides, total
cholesterol, low-density lipoprotein cholesterol, antinu-
clear antibodies, anti-neutrophil cytoplasmic antibodies,
prothrombin time, and tumor markers. The patient was
given medical treatment consisting of aspirin (100 mg per
day), clopidogrel (75 mg), and atorvastatin (20 mg). The
patient received combined anti-platelet treatment with
100 mg of aspirin and 75 mg of clopidogrel daily for a
week prior to the intervention. Under local anesthesia, the
patient underwent placement of a left carotid artery stent
(Fig. 1h, i). The patient was discharged 3 days post-
operatively. Two months after CAS, the patient experi-
enced right limb numbness and mild dysphasia with a
severe headache. The recurrent symptoms and each epi-
sode lasted approximately 2 min. An emergency cranial
MRI showed massive hyperintense lesions in the left tem-
poral and occipital lobes with ventricular compression(Fig. 2a, b). The cranial CT performed on the same day in-
dicated no cerebral hemorrhage (Fig. 2c). A neurologic
examination was also negative. On the basis of a detailed
medical history, a diagnosis of hyperfusion was proposed;
an anti-hypertensive and mannitol were introduced, and
aspirin was discontinued. Despite the medical treatment,
the headache worsened. A repeat cranial CT revealed that
the cerebral edema had worsened (Fig. 2d). Based on the
failed medical treatment and imaging features, a brain
tumor was considered. Repeat MRI showed multiple ring-
enhanced lesions in the left temporal, parietal, and occipi-
tal lobes complicated by massive brain edema (Fig. 2e, f ).
The patient underwent whole-body positron emission
tomography–computed tomography (PET/CT), which
showed that the increased FDG metabolism in the left
parietal and temporal lobes was consistent with malignant
lesions. Revised medical treatment included albumin,
furosemide, and dexamethasone. Then, the patient was
transferred to the neurosurgery ward pre-operatively. The
final pathologic diagnosis was glioblastoma multiforme
(WHO grade IV). A post-operative intracranial CT showed
regression of the cerebral edema (Fig. 2g, h).
Discussion
GBM is a malignant tumor with a dismal prognosis that is
often associated with extensive angiogenesis due to tumor
secretion and local effects exerted by vascular endothelial
growth factor, a major regulator of angiogenesis and other
Fig. 2 Images 2 months after carotid artery stenting. a, b (2015-3-24): T2-weighted image showed a massive lesion with edema in the left temporal and
occipital lobes. c (2015-3-24): CT image also found a massive lesion with edema in the left temporal and occipital lobes. d (2015-3-29): The repeat cranial
CT revealed that cerebral edema worsened. e, f (2015-4-11): contrast T1-weighted images showed multiple ring-enhanced lesions with massive edema in
the left temporal and occipital lobes. g, h (2015-4-29): Repeat cranial CT scans showed edema regressed 2 weeks post-operatively
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sented with ischemic stroke and severe ipsilateral carotid
artery stenosis and an intracranial massive lesion worsened
after CAS. Cerebral hyperfusion syndrome was suspected
due to headaches, cerebral edema, focal neurologic deficits,
serial images, and a pathologic diagnosis of a GBM. Hyper-
perfusion syndrome is a relatively rare complication of ca-
rotid artery revascularization procedures and may have
adverse clinical consequences in 1.1–25.0 % of patients
after CAS [4]. Delayed hyperperfusion syndrome has been
reported [4], which may be related to prolonged impair-
ment of cerebrovascular autoregulation. Some questions
remain which should be addressed. The course of the
disease was approximately 2 years, and the patient had
numerous atherosclerotic risks, including hypertension,
smoking, and coronary artery disease. The patient had
right limb weakness and numbness, amaurosis, and mild
dysphasia. MRI showed a left internal border zone cerebral
infarction and severe left carotid artery stenosis. Thus, an
ischemic stroke was not only misdiagnosed, but CAS was
reasonable. Imaging features of GBM have no special
characteristics. Multiple model MRI images are useful in
the diagnosis of GBM and its tumor grade [2, 5–7]. The
characteristic MRI findings of GBM include enhanced het-
erogeneous ring mass lesions with significant peritumoral
cerebral edema, necrosis, or hemorrhage [5, 7]. These fea-
tures also occur in patients with ischemic strokes [8, 9].
GBMs often pose a diagnostic dilemma on anatomic MRI
and may require a surgical biopsy for a definitive diagnosis.
In the current patient, whole-body PET/CT revealed no
systemic tumor and brain metastasis was ruled out.Did CAS prompt the growth of the GBM? The left
cerebral hemisphere was ischemic secondary to severe
carotid artery stenosis, while the GBM was dependent
on the blood supply. Brain ischemia and the GBM were
improved when the left carotid artery stenosis was recana-
lized, which may induce tumor growth. Relative cerebral
blood volume (rCBV) maps and measurements have been
shown to correlate reliably with tumor grade and histo-
logic findings of increased tumor vascularity [5, 7, 10]. In
addition, a study has proved that if the rCBV is >1.75,
there is a high probability that the tumor will be a high-
grade glioma [5]. GBM complicated with carotid artery
stenosis is rarely reported, and there is insufficient evi-
dence to prove a relationship between a worsening tumor
and CAS.
Conclusions
A GBM is a high-grade tumor with a dismal prognosis;
complication with severe ipsilateral carotid artery stenosis
is rare. Although ischemic stroke is a common disease, we
should make the diagnosis cautiously to avoid misdiag-
nosis. There is insufficient evidence that stent therapy for
carotid artery stenosis will aggravate an ipsilateral GBM.
Thus, we should be careful in performing CAS when a
patient has a concomitant GBM.
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